We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Study
Team
sleep.wearables@nhs.net
Dr
Michele
Hu
michele.hu@ndcn.ox.ac.uk
Adriana
Nastasa
adriana.nastasa@ndcn.ox.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Episodic and paroxysmal disordersExtrapyramidal and movement disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Sleep disorders are increasingly recognised as an important feature of various neurodegenerative diseases. They contribute to reduced quality of life and are associated with other poor outcome measures. Furthermore, it is now clear that sleep disorders can precede the onset of neurodegenerative disease and can therefore act as a marker of prodromal disease. The most important example of this relates to PD. Up to half of PD patients are thought to suffer from RBD, and many of these people develop RBD several years before the onset of PD. Recent cohort studies around the world and in Oxford have demonstrated that up to 80% of people diagnosed with RBD will go on to develop PD or another closely related disorder. The identification of people with RBD is therefore important in facilitating the earlier diagnosis of PD and in enabling the investigation of treatments which may delay or possibly prevent the onset of PD.
This study aims to investigate whether wearable device technology could be used as a potential diagnostic tool in the early clinical detection of RBD. The study would look to directly compare the performance of these devices against the use of PSG which is standard practice. In the second phase these devices will be assessed for their use as a tool to detect RBD in a PD patient cohort, assess the response of patients with RBD to treatment and lastly to look for the early progression of patients with RBD to PD.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Type: Device;Active Monitoring;
You can take part if:
You may not be able to take part if:
• Severe medical or psychiatric illness that would interfere with completing the required assessments • Severe mental impairment due to dementia or psychosis such that they lack capacity to make informed decisions • Active pregnancy • Active participation in a drug trial • Use of medication which in view of the PI is judged to significantly affect sleep quality and the recording
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Adriana
Nastasa
adriana.nastasa@ndcn.ox.ac.uk
Dr
Michele
Hu
michele.hu@ndcn.ox.ac.uk
Study
Team
sleep.wearables@nhs.net
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Oxford and funded by NIHR Oxford Biomedical Research Centre .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 36773
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
